Osteoporosis and osteomalacia - clinical and diagnostic problems

Cover Page


Cite item

Full Text

Abstract

Aim: to define main clinical and diagnostical problems related to osteoporosis and osteomalacia. Literature data showed that not only osteoporosis but osteomalacia may be the reason for decreasing of mechanical properties of skeleton with risk of low-energy fractures. The solution of associated medical and social problems is difficult because DEXA does not allow to differentiate between osteoporosis and osteomalacia that leads to misdiagnosis and unnecessary prescription of antiosteoporotic drugs. This approach is pathogenetically unproved and even may be harmful for the patient. Osteoporosis and osteomalacia does not exclude each other so bone mass reducing in one cohort of patient may be due to osteoporosis, other - osteomalacia and some of them - combinations of both. Another point is that results of controlled clinical trials that evaluated efficacy of antiosteoporotic drugs without differentiative histology tests for osteoporosis and osteomalacia are of doubtful value. As the bone biopsy that is necessary for osteomalacia diagnosis is invasive procedure there is need in definition of clear criteria when it has to be done in patient with reduced bone mass.

About the authors

A. S. Avrunin

Vreden Russian Research Institute of Traumatology and Orthopedics

Author for correspondence.
Email: a_avrunin@mail.ru
Россия

References

  1. Аврунин А.С., Корнилов Н.В., Суханов А.В., Емельянов В.Г. Формирование остеопоротических сдвигов в структуре костной ткани (костные органы, структура костной ткани и ее ремоделирование, концепция патогенеза остеопороза, его диагностики и лечения). СПб.:Ольга; 1998. 68 с.
  2. Аврунин А.С., Паршин Л.К., Аболин А.Б. Взаимосвязь морфофункциональных сдвигов на разных уровнях иерархической организации кортикальной кости при старении. Морфология. 2006;(3):22-29.
  3. Аврунин А.С., Тихилов Р.М., Шубняков И.И. Медицинские и околомедицинские причины высокого внимания общества к проблеме потери костной массы. Анализ динамики и структуры публикаций по остеопорозу. Гений ортопедии. 2009;(3):5-11.
  4. Корнилов Н.В., Аврунин А.С. Адаптационные процессы в органах скелета. СПб.:МОРСАР АВ;2001. 296 c.
  5. Лесгафт П.Ф. О причинах, влияющих на форму костей. В кн.: Избранные труды. М.: Медицина; 1968. с. 27-36.
  6. Allgrove J. Metabolic bone disease. Paediatrics and child health. 2010;(4):87-193.
  7. Anderson E.J., Knothe Tate M.L. Idealization of pericellular fluid space geometry and dimension results in a profound underprediction of nano-microscale stresses imparted by fluid drag on osteocytes. J Biomechanics. 2008;41(8):1736-1746.
  8. Anumula S., Magland J., Wehrlib S.L., Ong H., Song H.K., Wehrli F.W. Multi-modality study of the compositional and mechanical implications of hypomineralization in a rabbit model of osteomalacia. Bone. 2008;(2):405-413.
  9. Ascenzi M-G., Hetzer N., Lomovtsev A., Rude R., Nattiv A., Favia A. Variation of trabecular architecture in proximal femur of postmenopausal women. J Biomechanics. 2011;44(2):248-256.
  10. Åstrand J., Thorngren K-G., Tägil M. One fracture is enough! Experience with a prospective and consecutive osteoporosis screening program with 239 fracture patients. Acta Orthopaedica. 2006; 77(1): 3-8.
  11. Arya V., Jain V. Osteomalacia - what the rheumatologist needs to know. Indian J Rheumatology. 2007; 2(1);17-22.
  12. Bellido T., Saini V., Pajevic P.D. Effects of PTH on osteocyte function. Bone. 2013; 54(2):250-257
  13. Bener A., Hammoudeh M., Zirie M., Heller R.F. Is obesity a protective factor for osteoporosis? APLAR J Rheumatology. 2005;(8):32-38.
  14. Bhan A., Rao A.D., Rao D. S. Osteomalacia as a Result of Vitamin D Deficiency. Endocrinol Metab Clin N Am. 2010;39:321-331.
  15. Boivin G., Bala Y., Doublier A., Farlay D., Ste-Marie L.G., Meunier P.J., Delmas P.D. The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. Bone. 2008;(3):532-538.
  16. Bonnick S. L., Lewis L. A. Bone densitometry for Technologists. New Jersey: Humana press, 2006. 416 p.
  17. Cooper C., Barrett-Connor E. Epidemiology of osteoporosis. Osteoporosis 1996. Proceedings of the 1996 World Congress on Osteoporosis Amsterdam, The Netherlands, 18-23 May, 1996 Elsevier Science B.V. Amsterdam - Lausanne - New York - Oxford - Shannon - Tokyo, P-75-76.
  18. Cowin S.C. Bone mechanics handbook. London, New York, Washington: CRC Press LLC, Boca Raton, D.C.; 2001. 981 p.
  19. Cowin S.C. The significance of bone microstructure in mechanotransduction. J Biomech. 2007; 40 (Suppl.1):S105-S109.
  20. Davison K.S., Kendler D.L., Ammann P., Bauer D.C., Dempster D.W., Dian L., Hanley D.A., Harris S.T., McClung M.R., Olszynski W.P., Yuen C.K. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond. American J Medicine. 2009; 122(11):992-997.
  21. Demay M.B., Krane S.M. Disorders of calcification: osteomalacia and rickets. In: Endocrinology: adult and pediatric. Saunders; 2010. Chapter 70. p.1311-1329.
  22. Dempster D.W. Ремоделирование кости. В кн.: Остеопороз. Этиология, диагностика, лечение. СПб.: БИНОМ Невский диалект 2000, С. 85-107. * С работами автора можно ознакомиться по адресу: http://www.rniito.org/avrunin.html.
  23. Frost H.M. Why should many skeletal scientists and clinicians learn the Utah paradigm of skeletal physiology? J Musculoskel Neuron Interact. 2001;(2):121-130.
  24. Frost H.M. Tetracycline-based histological analysis of bone remodeling, Calcif Tissue Res. 1969;3:211-237.
  25. Frost H.M. From Wolff's law to the Utah paradigm: insights about bone physiology and its clinical applications. Anat. Rec. 2001;(4):398-419.
  26. Haugeberg G. Imaging of metabolic bone diseases. Best Practice & Research Clinical Rheumatology. 2008; 22(6):1127-1139.
  27. Hellmeyer L., Ossendor A., Ziller V., Tekesin I., Schmidt S. Hadji P. Quantitative ultrasonometry of the phalanges during pregnancy: a longitudinal study. Climacteric. 2006;9(6):446-451.
  28. Holick M.F. Optimal vitamin d status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017-1029.
  29. Hooven F.H., Adachi J.D., Adami S., Boonen S., Compston J., Cooper С., Delmas P., Diez-Perez A., Gchlbach S., Greenspan S.L., LaCroix A., Lindsay R., Netelenbos J.С., Pfeilschifter J., Roux C., Saag K.G., Sambrook P., Silverman S., Siris E., Watts N.B., Anderson F.A. The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int. 2009; 20(7):1107-1116.
  30. Horvai A.E., Boyce B.F. Metabolic bone diseases. Seminars in Diagnostic Pathology. 2011;(1):13-25.
  31. Johnston С.C., Melton III L.J. Костная денситометрия. В кн.: Остеопороз. Этиология, диагностика лечение. СПб.: БИНОМ Невский диалект; 2000. c. 297-320.
  32. Kanis J.A., McCloskey E.V., Johansson H., Oden A., Melton III L.J., Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;(3):467-475.
  33. Kornak U., Mundlos S. Genetic Disorders of the Skeleton: A Developmental Approach. Am J Hum Genet. 2003;73:447-474.
  34. Lee W.R. Bone formation in Paget's disease. A quantitative microscopic study using tetracycline markers. J Bone Joint Surg Br. 1967;(1):146-153.
  35. Lewiecki E.M., Bilezikian J.P., Cooper C., Hochberg M.C., Luckey M.M., Maricic M., Miller P.D. Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. J Clinical Densitometry: Assessment of Skeletal Health. 2008;(2):313-324.
  36. Lovejoy C.O., McCollum M.A., Reno P.L., Rosenman B.A. Developmental biology and human evolution. Annu Rev Anthropol. 2003;32:85-109.
  37. Mailhot G., Petit J.-L., Dion N., Deschenes C., Ste-Marie L.-G., Gascon-Barre M. Endocrine and bone consequences of cyclic nutritional changes in the calcium, phosphate and vitamin D status in the rat: An in vivo depletion-repletion-redepletion study. Bone. 2007;41(3):422-436.
  38. Marcus R., Feldman D., Nelson D.A., Rosen C.J. Fundamentals of osteoporosis. Academic Press. Amsterdam, Boston, Heidelberg, London, New York, Oxford, Paris, San Diego, San Francisco, Singapore, Sydney, Tokyo. 2010. 522 s.
  39. Melton III L.J. Эпидемиология переломов. В кн.: Остеопороз. Этиология, диагностика, лечение. СПб.: БИНОМ Невский диалект; 2000. c. 249-272.
  40. Nazarian A., Arroyo F.J.A., Rosso C., Aran S., Snyder B.D. Tensile properties of rat femoral bone as functions of bone volume fraction, apparent density and volumetric bone mineral density. J Biomech. 2011; 44(13):2482-2488.
  41. Nicolella D.P., Bonewald L.F., Moravits D.E., Lankford J. Measurement of microstructural strain in cortical bone. European J Morphology. 2005; 42(1/2):23-29.
  42. Pludowski P., Holick M., Pilz c S., Wagner C.L., Hollis B.W., Grant W.B., Shoenfeld Y., Lerchbaum E., Llewellyn D.J., Kienreich K., Soni M. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality - A review of recent evidence. Autoimmun Rev. 2013; 12(10):976-989.
  43. Priemel M., von Domarus C., Klatte T.O. et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2009;(2):305-312 цитировано по Rosen C.J. et al. (2011).
  44. Rosen C.J., Gallagher J.C. The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers teating patients with low bone mineral density. J Clinical Densitometry: Assessment of Skeletal Health. 2011;(2):79-84.
  45. Rowe S.M., Jung S.T., Lee J.Y. Epidemiology of osteoporosis in Korea. Osteoporos Int. 1997;(7)(Suppl. 3):S88-S90.
  46. Russell L.A. Osteoporosis and Osteomalacia. Rheum Dis Clin North Am. 2010; 36(4):665-680.
  47. Siminoski K., Leslie W.D., Frame H., Hodsman A., Josse R.G., Khan A., Lentle B.C., Lévesque J., Lyons D.J., Tarulli G., Brown J.P., Recommendations for Bone Mineral Density Reporting in Canada. JACR. 2005; 56(3):178-188.
  48. Simon L.S. Osteoporosis. Rheum Dis Clin North Am. 2007; 33(1):149-176.
  49. Skerry T.M. One mechanostat or many? Modifications of the site-specific response of bone to mechanical loading by nature and nurture. J. Musculoskelet Neuronal Interact. 2006;(2):122-127.
  50. Skerry T. Chapter 13. Mechanosensing in Bone and the Role of Glutamate Signalling. Mechanosensing Biology. Springer; 2011. p. 301-312.
  51. Skerry T.M., Lanyon L.E. Systemic and contralateral responses to loading of bones. J Bone Miner Res. 2009;(4):753.
  52. Turner C.H. Homeostatic control of bone structure: an application feedback theory. Bone. 1991;(3):203-217.
  53. Turner C.H., Takano Y., Owan I. Aging changes mechanical loading thresholds for bone formation in rats. J Bone Mineral Research. 1995;(10):1544-1549.
  54. Von Wolff J. Das Gesetz der Transformation der inneren Architektur der Knochen bei pathologischen Veränderungen der äusseren Knochenform. Sitzungsberichte der Käniglich Preussischen Akadkmie der Wissenschaften zu Berlin. Sitzung der phys.-math. Classe v. 21. April. - Mittheilung v. 13. Man. 1884, 23 p.
  55. Warriner A.H., Patkar N.M., Curtis J.R., Delzell E., Gary L., Kilgore M., Saag K. Which fractures are most attributable to osteoporosis? J Clin Epidemiol. 2011; 64(1):46-53.
  56. Whyte M.P., Thakker R.V. Rickets and osteomalacia. Medicine. 2009; 37(9):483-488.
  57. Wu M., Fannin J., Rice K.M., Wang B., Blough E.R. Effect of aging on cellular mechanotransduction. Ageing Research Reviews. 2011; (10):1-15.
  58. Yoshida T., Stern P.H. How vitamin D works on bone. Endocrinol Metab Clin North Am. 2012; 41(3):557-569.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies